Evidence map›Paper›PMID 35059128›Full record

ArticleACS medicinal chemistry letters2022

Large-Scale Screening of Antifungal Peptides Based on Quantitative Structure-Activity Relationship.

Jin Zhang, Longbing Yang, Zhuqing Tian, Wenjing Zhao, Chaoqin Sun, Lijuan Zhu, Mingjiao Huang, Guo Guo, Guiyou Liang

Abstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Machine Learning Accelerates De Novo Design of Antimicrobial Peptides.Interdisciplinary sciences, computational life sciences · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Specific Focus on Antifungal Peptides against Azole ResistantJournal of fungi (Basel, Switzerland) · 2022
    Review
  17. The Antimicrobial Peptide AMP-17 Derived fromAntibiotics (Basel, Switzerland) · 2022
    Article
  18. Designed Multifunctional Peptides for Intracellular Targets.Antibiotics (Basel, Switzerland) · 2022
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jin ZhangSchool of Public Health, Guizhou Medical University, Guiyang 550025, China.ORCID https://orcid.org/0000-0003-3074-5647
Longbing YangSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Zhuqing TianSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Wenjing ZhaoSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Chaoqin SunSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Lijuan ZhuSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Mingjiao HuangSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Guo GuoSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Guiyou LiangTranslational Medicine Research Center, Guizhou Medical University, Guiyang 550025, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antifungal peptides are effective, biocompatible, and biodegradable, and thus, they are promising to be the next generation of drugs for treating infections caused by fungi. The identification processes of highly active peptides, however, are still time-consuming and labor-intensive. Quantitative structure-activity relationships (QSARs) have dramatically facilitated the discovery of many bioactive drug molecules without

Identifiers

PMID35059128
PMCPMC8762751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.